Quick Takeaways
- Hongbo Lu has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $15,174,107.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Hongbo Lu and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original Filing| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ZBIO | Zenas BioPharma, Inc. | Director | $7,950,091 | +$7,154,900 | +900% | 31 Mar 2026 |
| TERN | Terns Pharmaceuticals, Inc. | Director | $4,999,995 | 11 Jun 2025 | ||
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Director | $2,224,021 | 16 Dec 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|